Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use

作者: Sergey Gorlatov , Godfrey Jonah Anderson Rainey , Leslie S. Johnson , Laura Lerner

DOI:

关键词: Wild typeEffectorBiochemistryBiologyPeptide sequenceFucosylationFc receptorAntibodyFragment crystallizable regionInflammation

摘要: The present invention relates to Fc region-containing polypeptides that exhibit improved effector function due alterations of the extent fucosylation, and methods using such for treating or preventing cancer other diseases. are preferably immunoglobulins (e.g., antibodies), in which region comprises at least one amino acid substitution relative corresponding sequence a wild type region, is sufficient attenuate post-translational fucosylation mediate binding an activating receptor reduced inhibitory receptor. particularly useful preventing, treating, ameliorating more symptoms associated with disease, disorder, infection where either enhanced efficacy cell mediated by FcγR desired cancer, infectious disease) inhibited response inflammation, autoimmune disease).

参考文章(581)
Raphael Clynes, Jeffrey V. Ravetch, Toshiyuki Takai, Diana Sylvestre, Mice mutant for functional Fc receptors and method of treating autoimmune diseases ,(1994)
Alan N. Houghton, David A. Scheinberg, Monoclonal antibody therapies-a 'constant' threat to cancer. Nature Medicine. ,vol. 6, pp. 373- 374 ,(2000) , 10.1038/74621
Larry W Tjoelker, David W Meyer, Lisa A Schubert, Michel Schummer, Haller Priska D Von, Biological targets for the diagnosis, treatment and prevention of cancer ,(2006)
Elaine Y. Lin, Valerie Gouon-Evans, Andrew V. Nguyen, Jeffrey W. Pollard, The macrophage growth factor CSF-1 in mammary gland development and tumor progression. Journal of Mammary Gland Biology and Neoplasia. ,vol. 7, pp. 147- 162 ,(2002) , 10.1023/A:1020399802795
ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood. ,vol. 83, pp. 435- 445 ,(1994) , 10.1182/BLOOD.V83.2.435.435
R. A. Reisfeld, S. Sell, Monoclonal antibodies and cancer therapy UCLA symposium on molecular and cellular biology. Annual meeting. 14. pp. 33- 74 ,(1985)
ZK Indik, JG Park, S Hunter, AD Schreiber, The molecular dissection of Fc gamma receptor mediated phagocytosis Blood. ,vol. 86, pp. 4389- 4399 ,(1995) , 10.1182/BLOOD.V86.12.4389.BLOODJOURNAL86124389
Jeffrey S Gerber, David M Mosser, Stimulatory and inhibitory signals originatingfrom the macrophage Fcγ receptors Microbes and Infection. ,vol. 3, pp. 131- 139 ,(2001) , 10.1016/S1286-4579(00)01360-5
Dennis R. Burton, Jenny M. Woof, Human antibody effector function. Advances in Immunology. ,vol. 51, pp. 1- 84 ,(1992) , 10.1016/S0065-2776(08)60486-1